Dextrose injection

Health care provider letter

DHCP Letter 1 DHCP Letter 2 DHCP Letter 3 DHCP Letter 4 DHCP Letter 5 DHCP Letter 6 DHCP Letter 7 DHCP Letter 8 DHCP Letter 9 DHCP Letter 10 DHCP Letter 11 DHCP Letter 12 DHCP Letter 13 DHCP Letter 14 DHCP Letter 15 DHCP Letter 16 DHCP Letter 17

Ingredients and appearance - Product information

Dextrose injection- Dextrose monohydrate

Product information

Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC: 0338-9536
Route of Administration Intravenous

Active Ingredient/Active Moiety

Ingredient Name Strength
Dextrose monohydrate ( UNII: LX22YL083G)( Anhydrous dextrose - UNII: 5SL0G7R0OK ) 2.5 gin 50 mL

Product Characteristics

Marketing Information

Marketing Category Application Number or Monograph Citation Territorial Authority Marketing Start Date
Unapproved drug for use in drug shortage USA

Dextrose injection- Dextrose monohydrate

Product information

Product Type HUMAN PRESCRIPTION DRUG LABEL Item Code (Source) NDC: 0338-9539
Route of Administration Intravenous

Active Ingredient/Active Moiety

Ingredient Name Strength
Dextrose monohydrate ( UNII: LX22YL083G)( Anhydrous dextrose - UNII: 5SL0G7R0OK ) 5 gin 100 mL

Product Characteristics

Marketing Information

Marketing Category Application Number or Monograph Citation Territorial Authority Marketing Start Date
Unapproved drug for use in drug shortage USA

Labeler - Baxter Healthcare Corporation( 005083209)

Establishment

Name ID/FEI Business Operations
Baxter Healthcare Corporation 005083209 ANALYSIS( 0338-9536, 0338-9539), MANUFACTURE( 0338-9536, 0338-9539), LABEL( 0338-9536, 0338-9539), PACK( 0338-9536, 0338-9539), STERILIZE( 0338-9536, 0338-9539)

Package/label principal display panel

JB0040
50 mL
DIN 00060348
Mini-Bag Plus
5% Dextrose Injection USP

Bar Code
(01)00809080000944

APPROX mOsmol/L 252 pH 4.0 SINGLE DOSE / DOSAGE UNIQUE
PER/PAR 50 mL DEXTROSE HYDROUS USP / DEXTROSE HYDRATE USP
2.5 g pH MAY BE ADJUSTED WITH SODIUM HYDROXIDE / IV FLUID NUTRI-
ENT REPLENISHER / DIRECTION SHEET AVAILABLE UPON REQUEST /
MUST NOT BE USED IN SERIES CONNECTIONS/ DO NOT ADMINISTER
SIMULTANEOUSLY WITH BLOOD / SQUEEZE AND INSPECT BAG / DISCARD
IF LEAKING / STORE AT 15C TO 25 C
pH PEUT ETRE AJUSTE AVEC DE LHYDROXYDE DE SODIUM / SOLUTION IV POUR NUTRITION
PARENTERALE / FEUILLE DE MODE DEMPLOI DISPONIBLE SUR DEMANDE / NE DOIT PAS ETRE
MONTE EN SERIE / NE PAS ADMINISTRER SIMULTANEMENT AVEC LE SANG / PRESSER ET
INSPECTER LE SAC / JETER EN CAS DE FUITES / GARDER ENTRE 15C ET 25 C
NONPYROGENIC / STERILE / APYROGENE
Viaflex® PVC CONTAINER / CONTENANT DE PVC

ACTIVATE BEFORE USE
ACTIVER AVANT DUTILISER

Baxter Logo
Baxter Corporation
Mississauga ON L5N 0C2

No Latex Symbol
88-70-20-290

JB0041
100 Ml
DIN 00060348
Mini-Bag Plus
5% Dextrose Injection USP

Bar Code
(01)00809080000951

APPROX mOsmol/L 252 pH 4.0
SINGLE DOSE / DOSAGE UNIQUE
PER/PAR 100 mL DEXTROSE HYDROUS USP / DEX-
TROSE HYDRATE USP 5 g pH MAY BE ADJUSTED
WITH SODIUM HYDROXIDE / IV FLUID NUTRIENT
REPLENISHER / DIRECTION SHEET AVAILABLE UPON
REQUEST / MUST NOT BE USED IN SERIES CONNECTIONS/ DO NOT
ADMINISTER SIMULTANEOUSLY WITH BLOOD / SQUEEZE AND INSPECT
BAG / DISCARD IF LEAKING / STORE AT 15C TO 25 C
pH PEUT ETRE AJUSTE AVEC DE LHYDROXYDE DE SODIUM /
SOLUTION IV POUR NUTRITION PARENTERALE / FEUILLE DE MODE
DEMPLOI DISPONIBLE SUR DEMANDE / NE DOIT PAS ETRE MONTE
EN SERIE / NE PAS ADMINISTRER SIMULTANEMENT AVEC LE SANG /
PRESSER ET INSPECTER LE SAC / JETER EN CAS DE FUITES /
GARDER ENTRE 15C ET 25 C
NONPYROGENIC / STERILE / APYROGENE
Viaflex® PVC CONTAINER / CONTENANT DE PVC

ACTIVATE BEFORE USE
ACTIVER AVANT DUTILISER

Baxter Logo
Baxter Corporation
Mississauga ON L5N 0C2

No Latex Symbol
88-70-20-292